Przejdź do zawartości
Merck

Analiza HPLC inhibitorów CYP3A w Ascentis® Express RP-Amide

Analiza HPLC inhibitorów CYP3A w Ascentis® Express RP-Amide application for HPLC

Materiały

Standardowe

Numer produktu
Opis
Cennik

N5536

Nefazodone hydrochloride

≥98% (HPLC), solid

S6319

Sertraline hydrochloride

≥98% (HPLC)

1279804

Fluoxetine hydrochloride

United States Pharmacopeia (USP) Reference Standard

1285909

Maleinian fluwoksaminy

United States Pharmacopeia (USP) Reference Standard

PHR1285

Lovastatin

Pharmaceutical Secondary Standard; Certified Reference Material

kolumna analityczna

Numer produktu
Opis
Cennik

53913-U

Ascentis® Express RP-Amide, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 10 cm × 2.1 mm

składnik fazy ruchomej

Numer produktu
Opis
Cennik

70221

Ammonium formate

eluent additive for LC-MS, LiChropur™, ≥99.0%

CONDITIONS

column

Ascentis Express RP-Amide, 10 cm x 2.1 mm I.D., 2.7 μm particles (53913-U)

mobile phase

[A] 20 mM ammonium formate in 50:50 (v/v) water:acetonitrile

flow rate

0.6 mL/min

column temp.

35 °C

detector

ESI(+), m/z 100-600

injection

1 μL

Opis

Komentarz do analizy

Ta aplikacja demonstruje przydatność Ascentis Express RP Amide do analizy inhibitorów CYP3A.

Informacje prawne

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Chromatogram Search

Related Product Categories

HPLC ColumnsGC Columns & AccessoriesTLC Plates & AdsorbentsSolid Phase Microextraction (SPME)Solid Phase Extraction & QuEChERS

Related Applications

Small Molecule HPLCLarge Molecule HPLCGas Chromatography (GC)TLCSolid Phase Microextraction (SPME)Solid Phase Extraction (SPE)QuEChERS